Food, Drugs, Healthcare, Life Sciences

The DEA's April 2026 final order creates a federal registration pathway for state-licensed medical marijuana operators, placing FDA-approved and state-licensed medical cannabis products on Schedule III...

This digest covers key virtual and digital health regulatory and public policy developments during March and early April 2026 from the United States, United Kingdom, and European Union.

On April 28, 2026, the Food and Drug Administration (FDA) unveiled two major announcements as part of its initiative to “advance the implementation of real-time clinical trials.” In conjunction with a request for information (RFI) for a proposed pilot program, the agency announced the successful initiation of two proof-of-concept real-time clinical trials (RTCTs). Taken together, the agency’s stated goal is to enable continuous trials and reduce the “hiatuses” between the phases of clinical development, ultimately improving the drug development process.

One does not need to be Miranda Priestly to observe that discounts are a trending topic for the US Department of Health and Human Services Office of Inspector General (OIG) advisory opinions (AOs).

Privacy compliance obligations continue to evolve quickly, as lawmakers and regulators refine rules governing data collection and security. As biometric technologies become more common in workplace and consumer-facing...

AbbVie advances its SKYRIZI subcutaneous treatment for Crohn's disease with FDA submission, while investing $1.4 billion in a North Carolina manufacturing campus.

One does not need to be Miranda Priestly to observe that discounts are a trending topic for the US Department of Health and Human Services Office of Inspector General (OIG) advisory opinions (AOs).

AbbVie advances its SKYRIZI subcutaneous treatment for Crohn's disease with FDA submission, while investing $1.4 billion in a North Carolina manufacturing campus.

This digest covers key virtual and digital health regulatory and public policy developments during March and early April 2026 from the United States, United Kingdom, and European Union.